A model of drug delivery to normal and cancer cells by antibody-targeted nanoliposomes. Sidorov IA, Blumenthal R, Dimitrov DS. 2006. Journal of Computational and Theoretical Nanoscience 3:405–411.
A novel microparticulate drug delivery system for the treatment of inflammatory bowel diseases. Kendall RA, Sudaxshina M, Abdul BW. 2006. Gastroenterology 130:A219–A219.
A shuttered neural probe with on-chip flowmeters for chronic in vivo drug delivery. Papageorgiou DP, Shore SE, Bledsoe SC, Wise KD. 2006. Journal of Microelectromechanical Systems 15:1025–1033.
A viral envelope as a vehicle for tracer, drug, and gene delivery - An initial biodistribution study using PET imaging. Flexman JA, Minoshima S, Kim Y, Miyoshi S, Lewellen BL, Cross DJ. 2006. IEEE Engineering in Medicine and Biology Magazine 25:70–75.
Abstracts from the Aerosol Society Drug Delivery to the Lungs XVI—Edinburgh International Conference Centre-Scotland, UK-December 8–9, 2005. Anon. 2006. Journal of Aerosol Medicine-Deposition Clearance and Effects in The Lung 19:222–241.
Abuse-resistant drug delivery. DuPont RL, Bensinger PB. 2006. Pediatric Annals 35:587.
Antimicrobial therapy using a local drug delivery system (Arestin (R)) in the treatment of peri-implantitis. I: microbiological outcomes. Persson GR, Salvi GE, Heitz-Mayfield LJA, Lang NP. 2006. Clinical Oral Implants Research 17:386–393.
Calcium phosphate cements as bone drug delivery systems: A review. Ginebra MP, Traykova T, Planell JA. 2006. Journal of Controlled Release 113:102–110.
Colonic drug delivery: Influence of cross-linking agent on pectin beads properties and role of the shell capsule type. Dupuis G, Chambin O, Genelot C, Champion D, Pourcelot Y. 2006. Drug Development and Industrial Pharmacy 32:847–855.
Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Orlu M, Cevher E, Araman A. 2006. International Journal of Pharmaceutics 318:103–117.
Design of functional dendritic polymers for application as drug and gene delivery systems. Sideratou Z, Tziveleka LA, Kontoyianni C, Tsiourvas D, Paleos CM. 2006. Gene Therapy And Molecular Biology 71:94.
Development of a new method for endovascular aortic repair - Combination therapy of cell transplantation and stent grafts with a drug delivery system. Kajimoto M, Shimono T, Hirano K, Miyake Y, Sawada Y, Kato N, Hirata H, Imanaka-Yoshida K, Nishikawa M, Yoshida T, Shimpo H, Horiuchi T, Miyamoto K. 2006. Circulation 378:383.
Development of pulsatile multiplarticulate drug delivery system coated with aqueous dispersion Aquacoat (R) ECD. Dashevsky A, Mohamad A. 2006. International Journal of Pharmaceutics 318:124–131.
Drug delivery and tissue engineering for reconstruction of the injured CNS. Shoichet MS. 2006. Journal of Neurotrauma 23:743–743.
Dry powder aerosol drug delivery—Opportunities for colloid and surface scientists. Chan HK. 2006. Colloids and Surfaces A-Physicochemical and Engineering Aspects 15:50–55.
Efficient delivery of anticancer drug MTX through MTX-LDH nanohybridsystem. Oh JM, Park M, Kim ST, Jung JY, Kang YG, Choy JH. 2006. Journal of Physics and Chemistry of Solids 67:1024–1027.
Engineering of composite particles for drug delivery using supercritical fluid technology. Shekunov BY, Chattopadhyay P, Seitzinger J. 2006. Polymeric Drug Delivery II: Polymeric Matrices and Drug Particle Engineering SE ACS 924:234–249.
Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Wu W, Wang Y, Que L. 2006. European Journal of Pharmaceutics and Biopharmaceutics 63:288–294.
Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(L-lactide) diblock copolymer for application in drug delivery. Hsiue GH, Wang CH, Lo CL, Wang CH, Li JP, Yang JL. 2006. International Journal of Pharmaceutics 317:69–75.
Enzymatic erosion of bioartificial membranes to control drug delivery. Coluccio ML, Ciardelli G, Bertoni F, Silvestri D, Cristallini C, Giusti P, Barbani N. 2006. Macromolecular Bioscience 6:403–411.
Feasibility of weekly HIV drug delivery to enhance drug localization in lymphoid tissues based on pharmacokinetic models of lipid-associated indinavir. Snedecor SJ, Sullivan SM, Ho RJY. 2006. Pharmaceutical Research 23:1750–1755.
Gas and particle dynamics of a contoured shock tube for pre-clinical microparticle drug delivery. Truong NK, Liu Y, Kendall MAF. 2006. Shock Waves 15:149–164.
Gels as vaginal drug delivery systems. das Neves J, Bahia MF. 2006. International Journal of Pharmaceutics 318:1–14.
Hair follicles - A long-term reservoir for drug delivery. Lademann J, Richter H, Schaefer UF, Blume-Peytavi U, Teichmann A, Otberg N, Sterry W. 2006. Skin Pharmacology and Physiology 19:232–236.
Hydroxybisphosphonate-containing polymeric drug-delivery systems designed for targeting into bone tissue. Hruby M, Etrych T, Kucka J, Forsterova M, Ulbrich K. 2006. Journal af Applied Polymer Science 101:3192–3201.
Improved health care delivery vs. drug investments. Lin KW. 2006. American Family Physician 74:166–166.
Injectable drug delivery based on polymer solutions: Experiment and modeling. McHugh AJ, DesNoyer JR, Raman C. 2006. Polymeric Drug Delivery II: Polymeric Matrices and Drug Particle Engineering SE ACS 924: 14–28.
Intracranial drug-delivery scaffolds: Biocompatibility evaluation of sucrose acetate isobutyrate gels. Lee J, Jallo GI, Penno MB, Gabrielson KL, Young GD, Johnson RM, Gillis EM, Rampersaud C, Carson BS, Guarnieri M. 2006. Toxicology and Applied Pharmacology 215:64–70.
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Dailey LA, Jekel N, Fink L, Gessler T, Schmehl T, Wittmar M, Kissel T, Seeger W. 2006. Toxicology and Applied Pharmacology 215:100–108.
Late bacterial granuloma at an intrathecal drug delivery catheter. Lehmberg J, Scheiwe C, Spreer J, van Velthoven V. 2006. Acta Neurochirurgica 148:899–901.
Late bacterial granuloma at an intrathecal drug delivery catheter -Comments. Hoff JT, Oyesiku NM. 2006. Acta Neurochirurgica 148:901–901.
Liposomes as targeted drug delivery systems in the treatment of breast cancer. Sharma G, Anabousi S, Ehrhardt C, Kumar MNVR. 2006. Journal of Drug Targeting 14:301–310.
Local delivery system of immune modulating drug for unresectable adenocarcinoma: In vitro experimental study and in vivo animal study. Lee DH, Kang SG, Jeong S, Yoon CJ, Choi JA, Byun JN, Park JH, Lee KB. 2006. Cardiovascular and Interventional Radiology 29:832–837.
Mesoscale modelling: recent developments and applications to nanocomposites, drug delivery and precipitation membranes. Maiti A, Wescott J, Goldbeck-Wood G. 2005. International Journal of Nanotechnology 2:198–214.
Microdermabrasion as a novel tool to enhance drug delivery via the skin: An animal study. Lee WR, Tsai RY, Fang CL, Liu CJ, Hu CH, Fang JY. 2006. Dermatologic Surgery 32:1013–1022.
Microencapsulation using natural polysaccharides for drug delivery and cell implantation. Wang W, Liu XD, Xie YB, Zhang H, Yu WT, Xiong Y, Xie WY, Ma XJ. 2006. Journal of Materials Chemistry 16:3252–3267.
Microprocessor controlled transdermal drug delivery. Subramony JA, Sharma A, Phipps JB. 2006. International Journal of Pharmaceutics 317: 1–6.
Molecular recognition and controlled release in drug delivery systems based on nanostructured lipid surfactants. Angius R, Murgia S, Berti D, Baglioni P, Monduzzi M. 2006. Journal of Physics-Condensed Matter 18:S2203–S2220.
Nanogel engineered designs for polymeric drug delivery. Morimoto N, Nomura SIM, Miyazawa N, Akiyoshi K. 2006. Polymeric Drug Delivery II: Polymeric Matrices and Drug Particle Engineering SE ACS 924:88–101.
Nanosystems for medical applications: Biological detection, drug delivery, diagnosis and therapy. Riviere C, Roux S, Tillement O, Billotey C, Perriat P. 2006. Annales De Chimie-Science Des Materiaux 31:351–367.
Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases. Couvreur P, Gref R, Andrieux K, Maivy C. 2006. Progress in Solid State Chemistry 34:231–235.
Neointima inhibition: Comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B. 2006. Radiology 240:411–418.
New onset lumbar radicular pain after implantation of an intrathecal drug delivery system: Imaging catheter migration. Ko WM, Ferrante FM. 2006. Regional Anesthesia and Pain Medicine 31:363–367.
Nifedipine solid dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blend for controlled drug delivery–Effect of drug loading on release kinetics. Huang JJ, Wigent RJ, Bentzley CM, Schwartz JB. 2006. International Journal of Pharmaceutics 319:44–54.
Novel alginate-acrylic polymers as a platform for drug delivery. Laurienzo P, Malinconico M, Mattia G, Russo R, La Rotonda MI, Quaglia F, Capitani D, Mannina L. 2006. Journal of Biomedical Materials Research Part A 523:531.
Novel drug delivery system using thermoreversible gelation polymer for malignant glioma. Arai T, Joki T, Akiyama M, Agawa M, Mori Y, Yoshioka H, Abe T. 2006. Journal of Neuro-Oncology 77:9–15.
Novel nanogels for drug binding and delivery. Somasundaran P, Liu F, Chakraborty S, Gryte CC, Deo N, Somasundaran T. 2006. Polymeric Drug Delivery II: Polymeric Matrices and Drug Particle Engineering SE ACS 924:69–87.
Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides). Trimaille T, Mondon K, Gurny R, Moller M. 2006. International Journal of Pharmaceutics 319:147–154.
Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering, Vallet-Regi M. 2006. Chemistry-A European Journal 12:5934–5943.
Perspectives on: Chitosan drug delivery systems based on their geometries. Denkbas EB, Ottenbrite RM. 2006. Journal of Bioactive and Compatible Polymers 21:351–368.
pH-responsive poly(styrene-alt-maleic anhydride) alkylamide copolymers for intracellular drug delivery. Henry SM, El-Sayed MEH, Pirie CM, Hoffman AS, Stayton PS. 2006. Biomacromolecules 7:2407-2414.
Phosphorous containing chitosan beads for controlled oral drug delivery. Jayakumar R, Reis RL, Mano JF. 2006. Journal of Bioactive and Compatible Polymers 21:327–340.
Poly(aspartic-acid) derivatives as polymeric micelle drug delivery systems. Jiang TY, Wang ZY, Chen C, Mo FK, Xu YL, Tang LX, Liang JJ. 2006. Journal of Applied Polymer Science 101:2871–2878.
Polymer therapeutics - polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities (Reprinted from Advances in Polymer Science, vol 192, pg 1-8, 2005). Duncan R, Ringsdorf H, Satchi-Fainaro R. 2006. Journal of Drug Targeting 14: 337–341.
Polymeric materials for ophthalmic drug delivery: trends and perspectives. Barbu E, Verestiuc L, Nevell TG, Tsibouklis J. 2006. Journal of Materials Chemistry 16:3439–3443.
Prediction of drug solubility in adhesive matrix for transdermal drug delivery based on a solvation parameter model. Li JW, Masso JJ. 2006. Polymeric Drug Delivery II: Polymeric Matrices and Drug Particle Engineering SE ACS 924:186–202.
Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improvedrug delivery. Martinive P, De Wever J, Bouzin C, Baudelet C, Sonveaux P, Gregoire V, Gallez B, Feron O. 2006. Molecular Cancer Therapeutics 5:1620-1627.
Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. Kieweg SL, Katz DF. 2006. Journal of Biomechanical Engineering-Transactions of the Asme 128:540–553.
Structure and function of the intercellular junctions: Barrier of paracellular drug delivery. Zheng K, Trivedi M, Siahaan TJ. 2006. Current Pharmaceutical Design 12:2813–2824.
Synthesis and evaluation of biocompatible pH-sensitive hydrogels as colon-specific drug delivery systems. Mahkam M, Mohammadi R, Siadat SOR. 2006. Journal of the Chinese Chemical Society 53:727-733.
The role of porous media in biomedical engineering as related to magnetic resonance imaging and drug delivery. Khanafer K, Vafai K. 2006. Heat and Mass Transfer 42:939–953.
Thermoresponsive drug delivery using liquid crystal-embedded cellulose nitrate membranes. Dinarvand R, Khodaverdi E, Atyabi F, Erfan M. 2006. Drug Delivery 13:345–350.
Thermosensitive poly(N-isopropylacrylamide)-b-poly(epsilon-caprolactone) nanoparticles for efficient drug delivery system. Choi C, Chae SY, Nah JW. 2006. Polymer 47:4571–4580.
Thermosensitive poly(organophosphazene) hydrogels for a controlled drugdelivery. Kang GD, Cheon SH, Khang G, Song SC. 2006. European Journal of Pharmaceutics and Biopharmaceutics 63:340–346.
Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Bernkop-Schnurch A, Weithaler A, Albrecht K, Greimel A. 2006. International Journal of Pharmaceutics 317:76–81.
Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: Implications for local drug delivery. Saito R, Krauze MT, Noble CO, Tamas M, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. 2006. Journal of Neuroscience Methods 154:225–232.
Transdermal delivery of ketoprofen: The influence of drug-dioleylphosphatidylcholine interactions. Garcia MTJ, da Silva CHTD, de Oliveira DCR, Braga ECA, Thomazini JA, Bentley MVLB. 2006. Pharmaceutical Research 23:1776–1785.